Tag: RHY

Rhythm Biosciences ColoSTAT biomarker colorectal cancer antibodies ASX RHY

Rhythm Biosciences reports positive results for lead biomarker in blood test for colorectal cancer screening

Australian medical diagnostics company Rhythm Biosciences (ASX: RHY) has confirmed the antibodies in a lead biomarker of a blood test for the accurate and early detection of colorectal cancer have bee...
Rhythm Biosciences RHY colorectal cancer test ColoSTAT cloning reagent

Rhythm Biosciences advances development of novel colorectal cancer test

Medical diagnostics technology company Rhythm Biosciences (ASX: RHY) is continuing the development of its novel test for colorectal cancer, named ColoSTAT. As part of this work, the company says it...
Rhythm Biosciences ASX RHY European patent ColoSTAT

Rhythm Biosciences secures European patent for cornerstone ColoSTAT product

Medical diagnostics technology company Rhythm Biosciences (ASX: RHY), has received some much-needed wind in its commercial sails after the company was granted a highly important European patent for it...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS